SUSMED,Inc. (TYO:4263)
Japan · Delayed Price · Currency is JPY 405.00
-6.00 (-1.46%)
Oct 6, 2026, 3:30 PM JST
SUSMED,Inc. Income Statement
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 497 | 462 | 342 | 530 | 316 | |
Revenue Growth | 7.58% | 35.09% | -35.47% | 67.72% | 174.78% |
Cost of Revenue | 18 | 12 | 12 | 8 | 11 |
Gross Profit | 479 | 450 | 330 | 522 | 305 |
Selling, General & Admin | 562 | 477 | 452 | 394 | 309 |
Research & Development | 247 | 273 | 243 | 176 | 226 |
Operating Expenses | 809 | 750 | 695 | 570 | 535 |
Operating Income | -330 | -300 | -365 | -48 | -230 |
Other Non Operating Income (Expenses) | 4 | 5 | 8 | 4 | 12 |
EBT Excluding Unusual Items | -326 | -295 | -357 | -44 | -218 |
Asset Writedown | -67 | -4 | -2 | -5 | -15 |
Other Unusual Items | 14 | 2 | 3 | - | - |
Pretax Income | -379 | -297 | -356 | -49 | -233 |
Income Tax Expense | 3 | 1 | 1 | 1 | - |
Net Income | -382 | -298 | -357 | -50 | -233 |
Net Income to Common | -382 | -298 | -357 | -50 | -233 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 17 | 17 | 17 | 16 | 15 |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 16 | 15 |
Shares Change | 0.33% | 0.60% | 1.77% | 11.71% | 14.76% |
EPS (Basic) | -22.67 | -17.75 | -21.39 | -3.05 | -15.87 |
EPS (Diluted) | -22.67 | -17.75 | -21.39 | -3.05 | -15.87 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -548 | -436 | -233 | 94 | -177 |
Free Cash Flow Per Share | -32.52 | -25.96 | -13.96 | 5.73 | -12.05 |
Gross Margin | 96.38% | 97.40% | 96.49% | 98.49% | 96.52% |
Operating Margin | -66.40% | -64.94% | -106.73% | -9.06% | -72.78% |
Profit Margin | -76.86% | -64.50% | -104.39% | -9.43% | -73.73% |
Free Cash Flow Margin | -110.26% | -94.37% | -68.13% | 17.74% | -56.01% |
EBITDA | -320 | -293 | -360 | -43 | -228 |
EBITDA Margin | -64.39% | -63.42% | -105.26% | -8.11% | -72.15% |
D&A For EBITDA | 10 | 7 | 5 | 5 | 2 |
EBIT | -330 | -300 | -365 | -48 | -230 |
EBIT Margin | -66.40% | -64.94% | -106.73% | -9.06% | -72.78% |